Current as of January 9, 2023

The health and safety of all AGBT attendees and stakeholders is our highest priority.  We will follow all CDC guidelines in place as of January 1, 2023.

For updates to our plan and information about our COVID-19 policies, bookmark this page or follow us on TwitterFacebook, or LinkedIn.


AGBT recommends that all attendees be fully vaccinated and have also received the most updated bivalent boosters targeting Omicron subvariants


AGBT strongly recommends the wearing of masks in crowded indoor settings.  Attendees should bring their own well-fitting face masks that cover the nose and mouth, securely.


In consideration of your colleagues:

  • AGBT encourages attendees to test for COVID-19, three days before departure to our meeting and to pack multiple self-test kits in your luggage
  • Do not attend AGBT if you test positive. Do not attend AGBT if you have symptoms that could be consistent with a “cold” or any other respiratory infection
  • If you begin experiencing symptoms on-site, you are encouraged to isolate and prepare to leave the meeting
  • Those who have tested positive in the prior ten-day period should not attend the meeting until they meet the CDC guidelines for ending isolation

You will be notified in advance of any changes to health requirements if AGBT determines a change is necessary.